Inogen Inc (CH:6IO)
NASDAQ:6IO
6IO Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
New Medical Device LaunchesAnalyst points to upcoming launches of a stationary oxygen concentrator and a CPAP mask as potential drivers to expand product revenue and strengthen market competitiveness.
Revenue DiversificationAnalyst emphasizes diversification efforts designed to broaden revenue sources beyond existing offerings, lowering reliance on any single market and smoothing growth volatility.
Turnaround And ProfitabilityAnalyst highlights that the company's ongoing turnaround and improved adjusted operating profitability could stabilize cash flow and reduce pressure on margins, supporting investor confidence.
Bears Say
Commodity Exposure RiskAnalyst warns that exposure to oil-related markets creates earnings volatility risk if energy sector demand weakens or pricing shifts.
Guidance Shortfall And Demand SoftnessAnalyst notes that revenue guidance coming in below consensus and misses across US, international, and rental channels point to broader demand softness that could pressure near-term growth expectations.
Order Delays And Sales WeaknessAnalyst reports that order delays have depressed sales and hurt reported results, indicating execution challenges and potential short-term cash flow pressure.
Inogen News
6IO FAQ
What was Inogen Inc’s price range in the past 12 months?
Currently, no data Available
What is Inogen Inc’s market cap?
Inogen Inc’s market cap is CHF130.38M.
When is Inogen Inc’s upcoming earnings report date?
Inogen Inc’s upcoming earnings report date is Aug 12, 2026 which is in 69 days.
How were Inogen Inc’s earnings last quarter?
Inogen Inc released its earnings results on May 07, 2026. The company reported -$0.234 earnings per share for the quarter, missing the consensus estimate of -$0.221 by -$0.013.
Is Inogen Inc overvalued?
According to Wall Street analysts Inogen Inc’s price is currently Undervalued.
Does Inogen Inc pay dividends?
Inogen Inc does not currently pay dividends.
What is Inogen Inc’s EPS estimate?
Inogen Inc’s EPS estimate is -0.12.
How many shares outstanding does Inogen Inc have?
Currently, no data Available
What happened to Inogen Inc’s price movement after its last earnings report?
Inogen Inc reported an EPS of -$0.234 in its last earnings report, missing expectations of -$0.221. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Inogen Inc?
Currently, no hedge funds are holding shares in CH:6IO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF9.44 (― Downside)
CHF9.44 (― Downside)
Blogger Sentiment
Bullish
CH:6IO Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-12.90%
Trailing 12-Months
Asset Growth
-7.29%
Trailing 12-Months
Company Description
Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
6IO Company Deck
6IO Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflects a company in transition: solid top-line growth driven by international expansion, strong unit volume gains, new product launches with encouraging early clinical and commercial signals, and a healthy balance sheet. Offsetting these positives are meaningful near-term headwinds in the U.S. market (declining direct and rental sales), higher operating losses due to accelerated R&D and commercial investments, and reliance on a FX tailwind. Management reaffirmed full-year guidance and expects EBITDA improvement, but several financial metrics remain under pressure in the near term.View all CH:6IO earnings summaries6IO Stock 12 Month Forecast
Average Price Target
$9.44
Options Prices
Currently, No data available
---